lunes, 26 de agosto de 2013

EGAPP Initiative: Value of an Honest Broker in Genomic Medicine


EGAPP Initiative: Value of an Honest Broker in Genomic Medicine

EGAPP logo
The EGAPP Initiative: Lessons learnedExternal Web Site Icon
EGAPP Working Group, Genetics in Medicine, Aug 8

The EGAPP Working GroupExternal Web Site Icon was established by CDC in 2005 to support the development of a systematic process for assessing the available evidence regarding the validity and utility of rapidly emerging genetic tests for clinical practice.
EGAPP methods update 2013External Web Site Icon
Veenstra et al., Genetics in Medicine (2012)

EGAPP approach to binning whole genome sequence information: a novel approach and pilot results. Adobe PDF file [PDF 656.44 KB]External Web Site Icon
Goddard K et al., Genetics in Medicine 2013
Guidelines for guideline developers: a systematic review of grading systems for medical tests.External Web Site Icon Implementation Science 2013. EGAPP ranked highest on methodologic characteristics
Breaking a vicious cycle.External Web Site Icon
Hayes DF, et al. Sci Transl Med. 2013 Jul 31;5(196):196cm6.
"We recommend that FDA adopts the EGAPP definitions [endorsed by the National Cancer Institute (NCI) and IOM] of analytical and clinical validity and clinical utility…"

No hay comentarios:

Publicar un comentario